Goldman Sachs’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-17,355
| Closed | -$22K | – | 6007 |
|
|
2021
Q4 | $22K | Buy |
+17,355
| New | +$22K | ﹤0.01% | 5450 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5607 |
|
|
2020
Q4 | – | Sell |
-91,731
| Closed | -$424K | – | 4809 |
|
|
2020
Q3 | $424K | Buy |
+91,731
| New | +$424K | ﹤0.01% | 3745 |
|
|
2020
Q2 | – | Sell |
-26,839
| Closed | -$65K | – | 4609 |
|
|
2020
Q1 | $65K | Buy |
26,839
+15,901
| +145% | +$38.5K | ﹤0.01% | 4232 |
|
|
2019
Q4 | $56K | Sell |
10,938
-7,375
| -40% | -$37.8K | ﹤0.01% | 4192 |
|
|
2019
Q3 | $118K | Buy |
18,313
+7,582
| +71% | +$48.9K | ﹤0.01% | 4025 |
|
|
2019
Q2 | $67K | Sell |
10,731
-12,667
| -54% | -$79.1K | ﹤0.01% | 4058 |
|
|
2019
Q1 | $249K | Buy |
23,398
+17,611
| +304% | +$187K | ﹤0.01% | 3807 |
|
|
2018
Q4 | $46K | Sell |
5,787
-15,357
| -73% | -$122K | ﹤0.01% | 3982 |
|
|
2018
Q3 | $409K | Sell |
21,144
-9,496
| -31% | -$184K | ﹤0.01% | 3526 |
|
|
2018
Q2 | $554K | Buy |
30,640
+9,352
| +44% | +$169K | ﹤0.01% | 3478 |
|
|
2018
Q1 | $227K | Sell |
21,288
-1,547
| -7% | -$16.5K | ﹤0.01% | 3801 |
|
|
2017
Q4 | $963K | Buy |
22,835
+16,893
| +284% | +$712K | ﹤0.01% | 3174 |
|
|
2017
Q3 | $327K | Sell |
5,942
-5,586
| -48% | -$307K | ﹤0.01% | 3685 |
|
|
2017
Q2 | $2.14M | Sell |
11,528
-4,181
| -27% | -$776K | ﹤0.01% | 2762 |
|
|
2017
Q1 | $1.88M | Sell |
15,709
-6,890
| -30% | -$824K | ﹤0.01% | 2776 |
|
|
2016
Q4 | $2.25M | Buy |
22,599
+17,036
| +306% | +$1.69M | ﹤0.01% | 2645 |
|
|
2016
Q3 | $623K | Buy |
5,563
+3,891
| +233% | +$436K | ﹤0.01% | 3308 |
|
|
2016
Q2 | $172K | Sell |
1,672
-442
| -21% | -$45.5K | ﹤0.01% | 3930 |
|
|
2016
Q1 | $194K | Buy |
+2,114
| New | +$194K | ﹤0.01% | 3789 |
|